Patent directory · USPTO A61K / A61P
Patents matching “anti-”
1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11649273
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11648318
Anti-transferrin receptor (TFR) antibody and uses thereof
granted -
US 11648307
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
granted -
US 11642390
Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
granted -
US 11633501
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof
granted -
US 11629195
Anti-IL2 receptor gamma antigen-binding proteins
granted -
US 11623010
Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment
granted -
US 11618784
Anti-CD47 combination therapy
granted -
US 11608380
Anti-EGFRvIII antibodies and uses thereof
granted -
US 11603413
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted -
US 11596690
Stabilized formulations containing anti-IL-33 antibodies
granted -
US 11596688
Predicting outcome of treatment with an anti-α4β7 integrin antibody
granted -
US 11596696
Combination therapy with an anti-CD25 antibody-drug conjugate
granted -
US 11578127
Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof
granted -
US 2023040008
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
granted -
US 11572372
Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds
granted -
US 11564937
Nucleoporins as drug targets for anti-proliferative therapeutics
granted -
US 11566076
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
granted -
US 11559576
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
granted -
US 11559583
Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer
granted -
US 11548947
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
granted -
US 11548940
Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11548932
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11541070
Administration of an anti-activin-A compound to a subject
granted